|
|
Volumn 4, Issue 2, 2014, Pages
|
|
BCL-2 inhibitor yields high response in CLL and SLL
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABT 199;
ANTINEOPLASTIC AGENT;
OBINUTUZUMAB;
RITUXIMAB;
UNCLASSIFIED DRUG;
APOPTOSIS;
CANCER RECURRENCE;
CELL PROLIFERATION;
CELL SURVIVAL;
CHRONIC LYMPHOCYTIC LYMPHOMA;
COUGHING;
DIARRHEA;
DRUG WITHDRAWAL;
FATIGUE;
FOLLOW UP;
HUMAN;
LYMPHOCYTOMA;
NEUTROPENIA;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PROTEIN EXPRESSION;
SMALL LYMPHOCYTIC LYMPHOMA;
TREATMENT RESPONSE;
TUMOR LYSIS SYNDROME;
UPPER RESPIRATORY TRACT INFECTION;
|
|
EID: 85047656056
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2013-178 Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|